Research in the Emory Division of Pulmonary, Allergy, Critical Care and Sleep Medicine covers a broad range of topics, including metabolomic analyses of nutritional and environmental factors in human health and disease; the basic mechanisms of lung development and the factors that control lung inflammation, injury, and repair/regeneration; and clinical/epidemiological studies in asthma, cystic fibrosis, pulmonary fibrosis, tuberculosis, and sepsis.
This work is currently funded by federal (National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense), industry and biotechnology companies and private foundation grants. It involves the use of diverse statistical and epidemiological techniques needed for the analysis of large national databases, and for conducting multicenter clinical trials. In addition, it takes advantage of sophisticated basic science methodologies including DNA macro- and microarrays, gene and protein delivery techniques, strategies for the inhibition of gene/protein functions, and models of lung disease using genetically engineered animals.
Clinical and Research Centers
- Adult Cystic Fibrosis Center
- Allergy, Asthma and Immunology
- Acute Lung Injury and Sepsis
- Emory Interstitial Lung Diseases Center
- Emory Program in Critical Care
- Interventional Pulmonology Program
- McKelvey Lung Transplant Center
- Pulmonary Hypertension Center for Translational Research in the Lung
- Vascular Biology
Emory Division of Pulmonary, Allergy, Critical Care and Sleep Medicine clinical trials.
Pulmonary, Allergy, Critical Care & Sleep Medicine News
Highlighted Researcher: Michael Hart
Frances Eun-Hyung Lee, MD receives $3.4 million U01 grant to develop more effective vaccines with sustained protection
Congratulations to featured Department of Medicine clinicians for 2019 National Doctors’ Day